» Articles » PMID: 34587909

Linear and Non-linear Analysis of Heart Rate Variability in HIV-positive Patients on Two Different Antiretroviral Therapy Regimens

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 Sep 30
PMID 34587909
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiac autonomic dysfunction in HIV+ patients on different antiretroviral therapy (ART) regimens has been described. We aimed to characterize parameters of heart rate variability (HRV) and correlate with different classes of ART in HIV+ patients in three experimental conditions: rest, cold face, and tilt tests.

Methods: Cross-sectional study with three groups of age- and gender-matched individuals: group 1, 44 HIV+ patients undergoing combination therapy, with two nucleoside reverse transcriptase inhibitors (NRTI) and one non-nucleoside reverse transcriptase inhibitor (NNRTI); group 2, 42 HIV+ patients using two NRTI and protease inhibitors (PI's); and group 3, 35 healthy volunteers with negative HIV serology (control group). Autonomic function at rest and during cold face- and tilt-tests was assessed through computerized analysis of HRV, via quantification of time- and frequency domains by linear and non-linear parameters in the three groups.

Results: Anthropometric and clinical parameters were similar between both HIV groups, except CD4+ T lymphocytes, which were significantly lower in group 2 (p = 0.039). At baseline, time-domain linear HRV parameters, RMSSD and pNN50, and the correlation dimension, a non-linear HRV parameter (p < 0.001; p = 0.018; p = 0.019, respectively), as well as response of RMSSD to cold face test were also lower in the HIV+ group than in the control individuals (p < 0.001), while no differences among groups were detected in HRV parameters during the tilt test.

Conclusions: Despite ART regimens, HIV+ patients presented lower cardiac vagal modulation than controls, whereas no difference was observed among the HIV groups, suggesting that higher cardiovascular risk linked to PIs may be associated with factors other than autonomic dysfunction.

Citing Articles

The Interplay of HIV and Long COVID in Sub-Saharan Africa: Mechanisms of Endothelial Dysfunction.

Chikopela T, Mwesigwa N, Masenga S, Kirabo A, Shibao C Curr Cardiol Rep. 2024; 26(9):859-871.

PMID: 38958890 DOI: 10.1007/s11886-024-02087-6.


Exploring outer space biophysical phenomena via SpaceLID.

Wang S, Wang T, Zeng X, Chu X, Zhuoma D, Zhao Y Sci Rep. 2023; 13(1):17400.

PMID: 37833498 PMC: 10575925. DOI: 10.1038/s41598-023-44729-9.


Autonomic Neuropathy as a Predictor of Morbidity and Mortality in People Living With HIV: A Retrospective, Longitudinal Cohort Study.

Kwon P, Lawrence S, Figueroa A, Robinson-Papp J Neurol Clin Pract. 2023; 13(3):e200141.

PMID: 37066108 PMC: 10092299. DOI: 10.1212/CPJ.0000000000200141.


Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics.

Rangon C, Niezgoda A Bioengineering (Basel). 2022; 9(8).

PMID: 36004877 PMC: 9405360. DOI: 10.3390/bioengineering9080352.

References
1.
Giovanetti M, Ciccozzi M, Parolin C, Borsetti A . Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview. Pathogens. 2020; 9(12). PMC: 7766877. DOI: 10.3390/pathogens9121072. View

2.
Piot P, Quinn T . Response to the AIDS pandemic--a global health model. N Engl J Med. 2013; 368(23):2210-8. PMC: 3777557. DOI: 10.1056/NEJMra1201533. View

3.
Bresciani E, Saletti C, Squillace N, Rizzi L, Molteni L, Meanti R . miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir. Front Pharmacol. 2019; 10:461. PMC: 6524698. DOI: 10.3389/fphar.2019.00461. View

4.
Cole S, Naliboff B, Kemeny M, Griswold M, Fahey J, Zack J . Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A. 2001; 98(22):12695-700. PMC: 60116. DOI: 10.1073/pnas.221134198. View

5.
Cade W, Reeds D, Lassa-Claxton S, Davila-Roman V, Waggoner A, Powderly W . Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?. HIV Med. 2007; 9(2):96-100. PMC: 4297631. DOI: 10.1111/j.1468-1293.2007.00524.x. View